Shrikant I. Bangdiwala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shrikant I. Bangdiwala has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Ami D. Sperber
Faculty of Health Sciences Ben‐Gurion University of the Negev Beer‐Sheva Israel
27 shared publications - Olafur S. Palsson
Center for Functional GI & Motility Disorders University of North Carolina‐Chapel Hill Chapel Hill North Carolina USA
14 shared publications Salim Yusuf
Population Health Research Institute, McMaster University, Hamilton, ON, Canada
11 shared publications- Magnus Simren
Department of Molecular and Clinical Medicine Institute of Medicine University of Gothenburg Gothenburg Sweden
8 shared publications - Sonia Savitri Anand
Population Health Research Institute, McMaster University, Hamilton, ON, Canada
8 shared publications Olafur S. Palsson
University of North Carolina/Chapel Hill Chapel Hill North Carolina USA
7 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (11)
Prevalence and Burden of Disorders of Gut–Brain Interaction in Nigeria: Results From the Rome Foundation Global Epidemiology Study
Background: Data on the prevalence and impact of disorders of gut–brain interaction (DGBI) are lacking for most parts of Africa, including Nigeria, the country with the largest population on the continent. This study aimed to investigate the prevalence and burden of DGBI among adults in the Nigerian general population. Methods: Nigerian data from the Rome Foundation Global Epidemiology Study (RFGES) were obtained by trained interviewers using face‐to‐face household interviews. The questionnaire included the Rome IV diagnostic questionnaire to assess the presence of DGBI, psychological distress (PHQ‐4), non‐GI somatic symptom severity (PHQ‐12), mental and physical quality of life (PROMIS‐10), health care utilization, and dietary intake. Key Results: One thousand six hundred and thirty‐two individuals (48.6% females, mean age 44 (range 18–100) years) were sampled. The prevalence of any DGBI in Nigeria was 23.5% (95% CI: 21.5–25.6), with a higher prevalence in females (26.1%) than in males (21.0%). The highest prevalence of DGBI per gastrointestinal anatomical region was for bowel disorders (17.6%). The most prevalent individual DGBI diagnoses were functional dyspepsia (7.3%) and unspecified functional bowel disorder (6.6%). Compared to individuals without DGBI, individuals with DGBI were older, had reduced quality of life, increased psychological symptoms and associated healthcare utilization burden. There was a higher prevalence of any DGBI reported in the northern regions than in the southern regions. Conclusions: DGBI are prevalent and impactful in Nigeria, in line with studies from other parts of the world that utilized the face‐to‐face survey methodology. More studies are needed to further understand the distribution and impact of DGBI in Nigeria and other similar countries around the world where they are understudied.
- 2 November 2026
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (11)
Open AccessPrevalence and Burden of Disorders of Gut–Brain Interaction in Nigeria: Results From the Rome Foundation Global Epidemiology Study
Background: Data on the prevalence and impact of disorders of gut–brain interaction (DGBI) are lacking for most parts of Africa, including Nigeria, the country with the largest population on the continent. This study aimed to investigate the prevalence and burden of DGBI among adults in the Nigerian general population. Methods: Nigerian data from the Rome Foundation Global Epidemiology Study (RFGES) were obtained by trained interviewers using face‐to‐face household interviews. The questionnaire included the Rome IV diagnostic questionnaire to assess the presence of DGBI, psychological distress (PHQ‐4), non‐GI somatic symptom severity (PHQ‐12), mental and physical quality of life (PROMIS‐10), health care utilization, and dietary intake. Key Results: One thousand six hundred and thirty‐two individuals (48.6% females, mean age 44 (range 18–100) years) were sampled. The prevalence of any DGBI in Nigeria was 23.5% (95% CI: 21.5–25.6), with a higher prevalence in females (26.1%) than in males (21.0%). The highest prevalence of DGBI per gastrointestinal anatomical region was for bowel disorders (17.6%). The most prevalent individual DGBI diagnoses were functional dyspepsia (7.3%) and unspecified functional bowel disorder (6.6%). Compared to individuals without DGBI, individuals with DGBI were older, had reduced quality of life, increased psychological symptoms and associated healthcare utilization burden. There was a higher prevalence of any DGBI reported in the northern regions than in the southern regions. Conclusions: DGBI are prevalent and impactful in Nigeria, in line with studies from other parts of the world that utilized the face‐to‐face survey methodology. More studies are needed to further understand the distribution and impact of DGBI in Nigeria and other similar countries around the world where they are understudied.
- Open Access
Integrated multiomic scores for cardiovascular disease prediction across multiancestral populations
Background: Genomic, epigenomic, and proteomic data capture complementary aspects of cardiovascular disease biology, but the value of integrating these data for predicting multiple cardiovascular disease outcomes across ancestry groups remains uncertain. Methods: We derived disease-specific proteomic scores using 999 plasma proteins in 50,673 UK Biobank participants and validated them in 9,358 participants from the Prospective Urban and Rural Epidemiological (PURE) study. In PURE, we integrated these proteomic scores with 2,279 polygenic scores and 479 DNA methylation scores to develop 4 multiomic scores (MEGASCOREs) for myocardial infarction (MI), atrial fibrillation (AF), heart failure (HF), and cardiovascular mortality. Associations with incident cardiovascular disease, discrimination, calibration, and performance across ancestry groups were evaluated in PURE and 2 additional cohorts. Results: In pooled analyses, each standard deviation increase in the corresponding MEGASCORE was associated with MI (hazard ratio [HR], 2.13; 95% CI, 1.86-2.43), AF (HR, 1.94; 95% CI, 1.68-2.24), HF (HR, 3.33; 95% CI, 2.75-4.05), and cardiovascular mortality (HR, 3.28; 95% CI, 2.33-4.61). MEGASCOREs improved discrimination compared with clinical models, with strongest improvements for HF and cardiovascular mortality. MEGASCORE CV-Death had a higher area under the receiver operating characteristic curve (AUC) than SCORE2 for cardiovascular mortality (0.83 [95% CI, 0.82-0.85] vs. 0.78 [95% CI, 0.77-0.80]). Its discrimination was also higher than that of SCORE2 across all 4 ancestry groups, with better calibration across non-European ancestry groups. MEGASCOREs remained associated with cardiovascular outcomes among participants without conventional cardiovascular risk factors. Conclusions: Integrated multiomic MEGASCOREs were associated with multiple cardiovascular outcomes and provided prognostic information beyond conventional clinical variables in PURE. Clinical Perspective: What is new?: We developed 4 cardiovascular disease-specific multiomic scores integrating proteomic signatures, polygenic scores, and DNA methylation scores to characterize risk of MI, AF, HF, and cardiovascular mortality. The MEGASCOREs were associated with incident cardiovascular disease outcomes and provided prognostic information beyond conventional clinical risk factors. MEGASCOREs showed consistent risk stratification across ancestry and remained associated with risk among participants without conventional cardiovascular risk factors. What are the clinical implications?: Integrated multiomic scores may complement conventional cardiovascular risk assessment by capturing molecular information not fully represented by clinical variables. Molecular risk profiling may help identify individuals with elevated cardiovascular risk despite having no conventional risk factors. Assessment of clinical utility, evaluation of implementation and cost-effectiveness are needed before MEGASCOREs can inform preventive treatment decisions.
Open AccessIntegrated multiomic scores for cardiovascular disease prediction across multiancestral populations
Background: Genomic, epigenomic, and proteomic data capture complementary aspects of cardiovascular disease biology, but the value of integrating these data for predicting multiple cardiovascular disease outcomes across ancestry groups remains uncertain. Methods: We derived disease-specific proteomic scores using 999 plasma proteins in 50,673 UK Biobank participants and validated them in 9,358 participants from the Prospective Urban and Rural Epidemiological (PURE) study. In PURE, we integrated these proteomic scores with 2,279 polygenic scores and 479 DNA methylation scores to develop 4 multiomic scores (MEGASCOREs) for myocardial infarction (MI), atrial fibrillation (AF), heart failure (HF), and cardiovascular mortality. Associations with incident cardiovascular disease, discrimination, calibration, and performance across ancestry groups were evaluated in PURE and 2 additional cohorts. Results: In pooled analyses, each standard deviation increase in the corresponding MEGASCORE was associated with MI (hazard ratio [HR], 2.13; 95% CI, 1.86-2.43), AF (HR, 1.94; 95% CI, 1.68-2.24), HF (HR, 3.33; 95% CI, 2.75-4.05), and cardiovascular mortality (HR, 3.28; 95% CI, 2.33-4.61). MEGASCOREs improved discrimination compared with clinical models, with strongest improvements for HF and cardiovascular mortality. MEGASCORE CV-Death had a higher area under the receiver operating characteristic curve (AUC) than SCORE2 for cardiovascular mortality (0.83 [95% CI, 0.82-0.85] vs. 0.78 [95% CI, 0.77-0.80]). Its discrimination was also higher than that of SCORE2 across all 4 ancestry groups, with better calibration across non-European ancestry groups. MEGASCOREs remained associated with cardiovascular outcomes among participants without conventional cardiovascular risk factors. Conclusions: Integrated multiomic MEGASCOREs were associated with multiple cardiovascular outcomes and provided prognostic information beyond conventional clinical variables in PURE. Clinical Perspective: What is new?: We developed 4 cardiovascular disease-specific multiomic scores integrating proteomic signatures, polygenic scores, and DNA methylation scores to characterize risk of MI, AF, HF, and cardiovascular mortality. The MEGASCOREs were associated with incident cardiovascular disease outcomes and provided prognostic information beyond conventional clinical risk factors. MEGASCOREs showed consistent risk stratification across ancestry and remained associated with risk among participants without conventional cardiovascular risk factors. What are the clinical implications?: Integrated multiomic scores may complement conventional cardiovascular risk assessment by capturing molecular information not fully represented by clinical variables. Molecular risk profiling may help identify individuals with elevated cardiovascular risk despite having no conventional risk factors. Assessment of clinical utility, evaluation of implementation and cost-effectiveness are needed before MEGASCOREs can inform preventive treatment decisions.
- Open Access
- 16 October 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (8) , e70311
Symptom Profiles Compatible With Disorders of Gut‐Brain Interaction in Individuals With Coeliac Disease on a Long‐Term Gluten‐Free Diet
Background: Persistent gastrointestinal (GI) symptoms are frequently reported in patients with coeliac disease (CD). Knowledge about the role of disorders of gut‐brain interaction (DGBI) as the cause of these persistent symptoms remains limited. Objective: To assess the prevalence and factors associated with DGBI‐compatible symptom profiles in individuals with CD on a long‐term gluten‐free diet (GFD). Methods: Adult members of the Dutch Coeliac Society completed an online survey, including the Rome IV diagnostic questionnaire and validated questionnaires assessing psychological distress, non‐GI somatic symptom severity, and health‐related quality of life (QOL). Only individuals with CD adhering to a GFD ≥ 1 year were included. A population‐based Dutch cohort served as the reference group. Results: Among 1001 participants with CD (79.3% female; median age 50 years), 64.8% met the criteria for ≥ 1 DGBI‐compatible symptom profile compared with 31.3% in the reference group (for confounders adjusted odds ratio (AOR) 3.2 (95% CI 2.6–3.8)). Irritable bowel syndrome showed the strongest association with CD (AOR 4.5 (95% CI 3.3–6.2)). Having DGBI‐compatible symptom profiles was, like the reference group, associated with higher levels of psychological distress and non‐GI somatic symptom severity and lower health‐related QOL. Conclusions: Rome IV DGBI‐compatible symptom profiles are highly prevalent in individuals with CD on a long‐term GFD and are associated with impaired QOL. While ongoing gluten exposure and other comorbidities could not be excluded, these findings support the consideration of DGBI in the evaluation and treatment of persistent symptoms in patients with CD.
- 16 October 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (8) , e70311
Open AccessSymptom Profiles Compatible With Disorders of Gut‐Brain Interaction in Individuals With Coeliac Disease on a Long‐Term Gluten‐Free Diet
Background: Persistent gastrointestinal (GI) symptoms are frequently reported in patients with coeliac disease (CD). Knowledge about the role of disorders of gut‐brain interaction (DGBI) as the cause of these persistent symptoms remains limited. Objective: To assess the prevalence and factors associated with DGBI‐compatible symptom profiles in individuals with CD on a long‐term gluten‐free diet (GFD). Methods: Adult members of the Dutch Coeliac Society completed an online survey, including the Rome IV diagnostic questionnaire and validated questionnaires assessing psychological distress, non‐GI somatic symptom severity, and health‐related quality of life (QOL). Only individuals with CD adhering to a GFD ≥ 1 year were included. A population‐based Dutch cohort served as the reference group. Results: Among 1001 participants with CD (79.3% female; median age 50 years), 64.8% met the criteria for ≥ 1 DGBI‐compatible symptom profile compared with 31.3% in the reference group (for confounders adjusted odds ratio (AOR) 3.2 (95% CI 2.6–3.8)). Irritable bowel syndrome showed the strongest association with CD (AOR 4.5 (95% CI 3.3–6.2)). Having DGBI‐compatible symptom profiles was, like the reference group, associated with higher levels of psychological distress and non‐GI somatic symptom severity and lower health‐related QOL. Conclusions: Rome IV DGBI‐compatible symptom profiles are highly prevalent in individuals with CD on a long‐term GFD and are associated with impaired QOL. While ongoing gluten exposure and other comorbidities could not be excluded, these findings support the consideration of DGBI in the evaluation and treatment of persistent symptoms in patients with CD.
- Open Access
- 15 October 2026
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 42 (7) , e70243
Diabetes Is Associated With Higher Symptom Burden in Patients With Disorders of Gut‐Brain Interaction: A Multinational Population‐Based Study
Aims: To compare multidomain symptom burden, psychological distress and healthcare utilisation across individuals with disorders of gut–brain interaction (DGBI) and diabetes and their overlap, and to assess obesity as an effect modifier. Materials and Methods: We conducted a cross‐sectional analysis based on data from the Rome Foundation Global Epidemiology Study. Participants were classified according to self‐reported physician‐diagnosed diabetes and Rome IV criteria for DGBI. Outcomes included gastrointestinal symptoms, psychological distress (PHQ‐4), somatic symptoms (PHQ‐12), healthcare utilisation, medication use and dietary intake. Results: Among 23,939 participants, 20,055 (83.8%) had DGBI only, 2205 (9.2%) had diabetes only and 1679 (7.0%) both. A consistent gradient was observed across most outcomes (overall p < 0.001), with the highest burden in the DGBI–diabetes overlap group, intermediate in DGBI alone and the lowest in diabetes alone. The overlap group exhibited greater gastrointestinal symptom severity (e.g., abdominal pain severity 51.4 ± 21.6 vs. 47.6 ± 22.2 vs. 45.8 ± 26.0), higher somatic symptom burden (7.2 ± 4.1 vs. 6.5 ± 3.7 vs. 4.5 ± 3.4) and increased healthcare utilisation, including more frequent physician visits (34.3% vs. 14.0% vs. 24.5%) compared with the DGBI‐only and diabetes‐only groups, respectively. Psychological distress was elevated in both DGBI groups compared with diabetes alone (overall p < 0.001). Obesity‐modified several associations between DGBI–diabetes overlap and clinical outcomes, with many associations being stronger among participants without obesity. Conclusions: Coexisting DGBI and diabetes were associated with greater gastrointestinal and somatic symptom burden and healthcare utilisation, including within the upper gastrointestinal and bowel DGBI domains. Obesity modified several of these associations, with stronger associations generally observed among participants without obesity.
- 15 October 2026
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 42 (7) , e70243
Open AccessDiabetes Is Associated With Higher Symptom Burden in Patients With Disorders of Gut‐Brain Interaction: A Multinational Population‐Based Study
Aims: To compare multidomain symptom burden, psychological distress and healthcare utilisation across individuals with disorders of gut–brain interaction (DGBI) and diabetes and their overlap, and to assess obesity as an effect modifier. Materials and Methods: We conducted a cross‐sectional analysis based on data from the Rome Foundation Global Epidemiology Study. Participants were classified according to self‐reported physician‐diagnosed diabetes and Rome IV criteria for DGBI. Outcomes included gastrointestinal symptoms, psychological distress (PHQ‐4), somatic symptoms (PHQ‐12), healthcare utilisation, medication use and dietary intake. Results: Among 23,939 participants, 20,055 (83.8%) had DGBI only, 2205 (9.2%) had diabetes only and 1679 (7.0%) both. A consistent gradient was observed across most outcomes (overall p < 0.001), with the highest burden in the DGBI–diabetes overlap group, intermediate in DGBI alone and the lowest in diabetes alone. The overlap group exhibited greater gastrointestinal symptom severity (e.g., abdominal pain severity 51.4 ± 21.6 vs. 47.6 ± 22.2 vs. 45.8 ± 26.0), higher somatic symptom burden (7.2 ± 4.1 vs. 6.5 ± 3.7 vs. 4.5 ± 3.4) and increased healthcare utilisation, including more frequent physician visits (34.3% vs. 14.0% vs. 24.5%) compared with the DGBI‐only and diabetes‐only groups, respectively. Psychological distress was elevated in both DGBI groups compared with diabetes alone (overall p < 0.001). Obesity‐modified several associations between DGBI–diabetes overlap and clinical outcomes, with many associations being stronger among participants without obesity. Conclusions: Coexisting DGBI and diabetes were associated with greater gastrointestinal and somatic symptom burden and healthcare utilisation, including within the upper gastrointestinal and bowel DGBI domains. Obesity modified several of these associations, with stronger associations generally observed among participants without obesity.
- Open Access
- 30 July 2026
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 32 (3) , 429-437
The Association Between Usual Diet and Bowel Disorders of Gut-Brain Interaction: Analyses From the Rome Foundation Global Epidemiology Study
Daniel Bushyhead, Rutaba Khatun, Shrikant I Bangdiwala, Olafur Palsson, Ami D Sperber, and Eamonn M M Quigley. J Neurogastroenterol Motil 2026;32:429-37. https://doi.org/10.5056/jnm25137
- 30 July 2026
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 32 (3) , 429-437
Open AccessThe Association Between Usual Diet and Bowel Disorders of Gut-Brain Interaction: Analyses From the Rome Foundation Global Epidemiology Study
Daniel Bushyhead, Rutaba Khatun, Shrikant I Bangdiwala, Olafur Palsson, Ami D Sperber, and Eamonn M M Quigley. J Neurogastroenterol Motil 2026;32:429-37. https://doi.org/10.5056/jnm25137
- Open Access
- 29 July 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (7)
Global Prevalence of Self‐Reported Alarm Features in the General Population and Among Individuals With Disorders of Gut–Brain Interaction—Results From the Rome Foundation Global Epidemiology Study
Background: Data on the global prevalence of alarm features in the general population and among individuals with disorders of gut–brain interaction (DGBI) are limited. Methods: We analysed data from the Rome Foundation Global Epidemiology Study to estimate the prevalence of fourteen self‐reported alarm features in the global population and among individuals with Rome IV defined DGBI, including 54,127 participants from 26 countries. Differences between participants with and without DGBI were evaluated in a sample excluding those with self‐reported organic gastrointestinal disease, using univariable logistic regression. Analyses were stratified by age (< 50 vs. ≥ 50 years). Results: Alarm features were reported by 63.1% of participants aged < 50 years and 51.8% of those aged ≥ 50 years. Individual self‐reported alarm features ranged from 0.9% to 18.3% in younger participants to 0.3%–13.3% in older participants. Haematemesis was the least frequently reported feature, while a major change in bowel movements was the most frequent in both age groups. Self‐reported alarm features were more frequent among participants with than without DGBI (< 50 years: 75.3% vs. 50.7%; OR 3.0 [2.8–3.1]; ≥ 50 years: 67.5% vs. 38.8%; OR 3.3 [3.1–3.5]). Participants with DGBI were also more likely to report multiple alarm features. Discussion: Self‐reported alarm features are common in the general population and more prevalent among individuals with DGBI. These findings underscore the importance of interpreting alarm features within a broader clinical context rather than in isolation. Further studies are needed to clarify the diagnostic utility of alarm features in unselected populations, particularly among individuals with DGBI.
- 29 July 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (7)
Open AccessGlobal Prevalence of Self‐Reported Alarm Features in the General Population and Among Individuals With Disorders of Gut–Brain Interaction—Results From the Rome Foundation Global Epidemiology Study
Background: Data on the global prevalence of alarm features in the general population and among individuals with disorders of gut–brain interaction (DGBI) are limited. Methods: We analysed data from the Rome Foundation Global Epidemiology Study to estimate the prevalence of fourteen self‐reported alarm features in the global population and among individuals with Rome IV defined DGBI, including 54,127 participants from 26 countries. Differences between participants with and without DGBI were evaluated in a sample excluding those with self‐reported organic gastrointestinal disease, using univariable logistic regression. Analyses were stratified by age (< 50 vs. ≥ 50 years). Results: Alarm features were reported by 63.1% of participants aged < 50 years and 51.8% of those aged ≥ 50 years. Individual self‐reported alarm features ranged from 0.9% to 18.3% in younger participants to 0.3%–13.3% in older participants. Haematemesis was the least frequently reported feature, while a major change in bowel movements was the most frequent in both age groups. Self‐reported alarm features were more frequent among participants with than without DGBI (< 50 years: 75.3% vs. 50.7%; OR 3.0 [2.8–3.1]; ≥ 50 years: 67.5% vs. 38.8%; OR 3.3 [3.1–3.5]). Participants with DGBI were also more likely to report multiple alarm features. Discussion: Self‐reported alarm features are common in the general population and more prevalent among individuals with DGBI. These findings underscore the importance of interpreting alarm features within a broader clinical context rather than in isolation. Further studies are needed to clarify the diagnostic utility of alarm features in unselected populations, particularly among individuals with DGBI.
- 1 July 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (7) , 2085-2097
Association of Air Pollution With Brain Health: A Cross-Sectional Analysis of Adults Living in Canada
BACKGROUND: Air pollution is a risk factor for dementia, but its role in early cognitive dysfunction is not clear. We aimed to investigate the association of air pollution with cognitive function, and the role of cardiovascular risk factors and greenspace in this association. METHODS: The CAHHM (Canadian Alliance for Healthy Hearts and Minds Cohort Study) is a cohort of Canadian adults recruited between 2014 and 2018, for whom averages of exposures to NO 2 and fine particulate matter were estimated for 5 years before recruitment. Outcomes included the Montréal Cognitive Assessment and Digit Symbol Substitution Test for cognitive function, and magnetic resonance imaging–measured covert vascular brain injury. Generalized linear mixed models assessed pollutant associations with outcomes in this cross-sectional analysis. RESULTS: A total of 6878 adults participated in the study, with a mean age of 57.6 years (SD=8.8), and 55.6% were women. Mean (SD; range) 5-year pollutant concentrations preceding enrollment for fine particulate matter were 6.9 μg/m 3 (2.0 [1.8–11.2]), and for NO 2 were 12.9 parts per billion (5.9 [0.9–33.9]). In adjusted models, a 5 μg/m 3 higher fine particulate matter concentration was associated with 0.44 points lower Montréal Cognitive Assessment (95% CI, −0.62 to −0.25) and 1.31 points lower Digit Symbol Substitution Test (95% CI, −2.41 to −0.22) scores. A 5 parts per billion higher NO 2 concentration was associated with 0.12 points lower Montréal Cognitive Assessment (95% CI, −0.17 to −0.07) and 0.38 points lower Digit Symbol Substitution Test (95% CI, −0.70 to −0.05) scores. A 5 parts per billion higher NO 2 concentration was associated with higher odds of covert vascular brain injury (adjusted odds ratio, 1.08 [95% CI, 1.00–1.17]). Cardiovascular risk factors and greenspace did not change these associations. CONCLUSIONS: Fine particulate matter and NO 2 were associated with lower cognitive function scores in middle-aged adults living in Canada, independent of cardiovascular risk factors. Our results warrant longitudinal follow-up to study the impact of air pollution on cognitive decline.
- 1 July 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (7) , 2085-2097
Association of Air Pollution With Brain Health: A Cross-Sectional Analysis of Adults Living in Canada
BACKGROUND: Air pollution is a risk factor for dementia, but its role in early cognitive dysfunction is not clear. We aimed to investigate the association of air pollution with cognitive function, and the role of cardiovascular risk factors and greenspace in this association. METHODS: The CAHHM (Canadian Alliance for Healthy Hearts and Minds Cohort Study) is a cohort of Canadian adults recruited between 2014 and 2018, for whom averages of exposures to NO 2 and fine particulate matter were estimated for 5 years before recruitment. Outcomes included the Montréal Cognitive Assessment and Digit Symbol Substitution Test for cognitive function, and magnetic resonance imaging–measured covert vascular brain injury. Generalized linear mixed models assessed pollutant associations with outcomes in this cross-sectional analysis. RESULTS: A total of 6878 adults participated in the study, with a mean age of 57.6 years (SD=8.8), and 55.6% were women. Mean (SD; range) 5-year pollutant concentrations preceding enrollment for fine particulate matter were 6.9 μg/m 3 (2.0 [1.8–11.2]), and for NO 2 were 12.9 parts per billion (5.9 [0.9–33.9]). In adjusted models, a 5 μg/m 3 higher fine particulate matter concentration was associated with 0.44 points lower Montréal Cognitive Assessment (95% CI, −0.62 to −0.25) and 1.31 points lower Digit Symbol Substitution Test (95% CI, −2.41 to −0.22) scores. A 5 parts per billion higher NO 2 concentration was associated with 0.12 points lower Montréal Cognitive Assessment (95% CI, −0.17 to −0.07) and 0.38 points lower Digit Symbol Substitution Test (95% CI, −0.70 to −0.05) scores. A 5 parts per billion higher NO 2 concentration was associated with higher odds of covert vascular brain injury (adjusted odds ratio, 1.08 [95% CI, 1.00–1.17]). Cardiovascular risk factors and greenspace did not change these associations. CONCLUSIONS: Fine particulate matter and NO 2 were associated with lower cognitive function scores in middle-aged adults living in Canada, independent of cardiovascular risk factors. Our results warrant longitudinal follow-up to study the impact of air pollution on cognitive decline.
- Open Access
- 24 June 2026
- Published by AOSIS in African Journal of Psychological Assessment
- Vol. 8
Comparing global and community indicators of safety and peace
Indicators measuring the progress of safety and peace have been pursued at a macro (global) and meso level (community). While global indicators focus on the country-level indicators, it does not consider the community-level contextually relevant needs of the indicators. While the global indicators present a general framework to measure safety and peace, these constructs are dynamic and fluid, and thus understood differently within and across countries, provinces and communities. Drawing on data collected through community participatory processes, this study aims to compare existing global indicators with community-level indicators of peace and safety and to evaluate the usefulness of these global indicators for measuring peace and safety at the community level. This study forms part of a larger study the Community Safety And Peace Index (CSPI) that aimed to develop a contextually and psychometrically valid and reliable instrument to assess, monitor and promote safety and peace at the community level. Contribution: The analysis of the data revealed several dimensions of safety and peace, including physical (dis)order, social (dis)order, community cohesion, structural security, social justice, affective and interpersonal relationships, crime and violence and values.
- 24 June 2026
- Published by AOSIS in African Journal of Psychological Assessment
- Vol. 8
Open AccessComparing global and community indicators of safety and peace
Indicators measuring the progress of safety and peace have been pursued at a macro (global) and meso level (community). While global indicators focus on the country-level indicators, it does not consider the community-level contextually relevant needs of the indicators. While the global indicators present a general framework to measure safety and peace, these constructs are dynamic and fluid, and thus understood differently within and across countries, provinces and communities. Drawing on data collected through community participatory processes, this study aims to compare existing global indicators with community-level indicators of peace and safety and to evaluate the usefulness of these global indicators for measuring peace and safety at the community level. This study forms part of a larger study the Community Safety And Peace Index (CSPI) that aimed to develop a contextually and psychometrically valid and reliable instrument to assess, monitor and promote safety and peace at the community level. Contribution: The analysis of the data revealed several dimensions of safety and peace, including physical (dis)order, social (dis)order, community cohesion, structural security, social justice, affective and interpersonal relationships, crime and violence and values.
- Open Access
- 5 May 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (4) , e70226
Comparative Study on Burden, Features and Determinants of Disorders of Gut‐Brain Interaction Between Southern Europe and the Rest of Continent: Results From the Rome Foundation Global Epidemiology Study
Background and Aim: Disorders of gut–brain interaction (DGBI) are highly prevalent worldwide. Although the epidemiology of DGBIs in Europe has been previously investigated, data comparing disease prevalence across European regions in relation to sociodemographic and lifestyle factors are lacking. Therefore, this study aimed to assess the prevalence, regional distribution, and associated factors of DGBI in Southern Europe, and to compare findings with other European regions. Methods: Data were drawn from the Rome Foundation Global Epidemiology Study (RFGES). A representative sample of 20,420 European adults completed a comprehensive internet‐based questionnaire assessing DGBI presence, psychological distress, somatic symptoms, dietary habits, and healthcare utilization. Comparative analyses were conducted between Southern European countries and the rest of the continent (Northern, Western, and Eastern European countries). Multivariate logistic regression identified independent associated factors. Results: The prevalence of adults with at least one DGBI was significantly higher in Southern Europe than in the rest of Europe (44.0% [42.4–45.5] vs. 39.0% [38.3–39.8]; p < 0.001). Irritable bowel syndrome and functional dyspepsia were more prevalent in Southern Europe than in the rest of Europe. Similar trends were found for functional constipation and functional diarrhea. Individuals with DGBI in Southern Europe showed higher psychological distress but lower somatic symptom burden and lower work productivity and activity impairment. In multivariable models, residence in Southern Europe, female sex, younger age, higher psychological distress, greater somatic symptom burden, higher educational attainment, urban residence and more frequent healthcare utilization were independently associated with DGBI. Conclusions: Southern European populations exhibit a higher prevalence of DGBI compared with other European regions. Individuals with DGBI in Southern Europe showed higher rates of psychological distress, whereas those in the rest of Europe showed higher somatic symptom burden, greater work productivity and activity impairment. DGBI rates in Europe appear to be driven by a multifactorial interplay of demographic and psychosocial factors.
- 5 May 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (4) , e70226
Open AccessComparative Study on Burden, Features and Determinants of Disorders of Gut‐Brain Interaction Between Southern Europe and the Rest of Continent: Results From the Rome Foundation Global Epidemiology Study
Background and Aim: Disorders of gut–brain interaction (DGBI) are highly prevalent worldwide. Although the epidemiology of DGBIs in Europe has been previously investigated, data comparing disease prevalence across European regions in relation to sociodemographic and lifestyle factors are lacking. Therefore, this study aimed to assess the prevalence, regional distribution, and associated factors of DGBI in Southern Europe, and to compare findings with other European regions. Methods: Data were drawn from the Rome Foundation Global Epidemiology Study (RFGES). A representative sample of 20,420 European adults completed a comprehensive internet‐based questionnaire assessing DGBI presence, psychological distress, somatic symptoms, dietary habits, and healthcare utilization. Comparative analyses were conducted between Southern European countries and the rest of the continent (Northern, Western, and Eastern European countries). Multivariate logistic regression identified independent associated factors. Results: The prevalence of adults with at least one DGBI was significantly higher in Southern Europe than in the rest of Europe (44.0% [42.4–45.5] vs. 39.0% [38.3–39.8]; p < 0.001). Irritable bowel syndrome and functional dyspepsia were more prevalent in Southern Europe than in the rest of Europe. Similar trends were found for functional constipation and functional diarrhea. Individuals with DGBI in Southern Europe showed higher psychological distress but lower somatic symptom burden and lower work productivity and activity impairment. In multivariable models, residence in Southern Europe, female sex, younger age, higher psychological distress, greater somatic symptom burden, higher educational attainment, urban residence and more frequent healthcare utilization were independently associated with DGBI. Conclusions: Southern European populations exhibit a higher prevalence of DGBI compared with other European regions. Individuals with DGBI in Southern Europe showed higher rates of psychological distress, whereas those in the rest of Europe showed higher somatic symptom burden, greater work productivity and activity impairment. DGBI rates in Europe appear to be driven by a multifactorial interplay of demographic and psychosocial factors.
- 9 April 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Association of Body Mass Index With Disorders of Gut-Brain Interaction: A Large Global Population-Based Analysis
INTRODUCTION: Individuals with underweight or obesity may have altered gut-brain signaling. This study investigated the association between body mass index (BMI) and the prevalence and burden of disorders of gut-brain interaction (DGBI). METHODS: This cross-sectional analysis used the internet-based data from the Rome Foundation Global Epidemiology Study, conducted in 2017–2018 across 26 countries. Adults aged 18 years or older with BMI data were included. DGBI were diagnosed according to the Rome IV criteria. Associations between BMI and DGBI were analyzed across BMI categories and for each 5 kg/m 2 increment above 25 kg/m 2 using mixed logistic regression models adjusted for age, sex, diabetes, psychological distress, and healthcare utilization. Additional analyses evaluated anatomical DGBI groups, overlapping disorders, and psychometric scales. RESULTS: Among 48,366 participants, the prevalence of DGBI followed a U-shaped pattern across BMI categories. After adjustment, underweight groups had similar odds of any DGBI compared with those with normal BMI, whereas the odds progressively increased for overweight and obesity groups (class I: 1.20; 95% confidence interval [CI] 1.13–1.29; class II: 1.23; 95% CI 1.11–1.36; class III: 1.52; 95% CI 1.32–1.74). Every 5 kg/m 2 BMI increase above 25 kg/m 2 raised DGBI odds by 8% (95% CI 4%–11%). Associations were strongest for esophageal and gastroduodenal disorders. Higher BMI was associated with worse physical and mental health and greater anxiety and depression, irrespective of the presence of DGBI. DISCUSSION: Higher, but not lower, BMI is independently associated with increased prevalence and symptom burden of DGBI. Obesity confers the highest odds for overlapping disorders and psychological disturbances, underscoring the importance of integrated metabolic and behavioral management strategies.
- 9 April 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Association of Body Mass Index With Disorders of Gut-Brain Interaction: A Large Global Population-Based Analysis
INTRODUCTION: Individuals with underweight or obesity may have altered gut-brain signaling. This study investigated the association between body mass index (BMI) and the prevalence and burden of disorders of gut-brain interaction (DGBI). METHODS: This cross-sectional analysis used the internet-based data from the Rome Foundation Global Epidemiology Study, conducted in 2017–2018 across 26 countries. Adults aged 18 years or older with BMI data were included. DGBI were diagnosed according to the Rome IV criteria. Associations between BMI and DGBI were analyzed across BMI categories and for each 5 kg/m 2 increment above 25 kg/m 2 using mixed logistic regression models adjusted for age, sex, diabetes, psychological distress, and healthcare utilization. Additional analyses evaluated anatomical DGBI groups, overlapping disorders, and psychometric scales. RESULTS: Among 48,366 participants, the prevalence of DGBI followed a U-shaped pattern across BMI categories. After adjustment, underweight groups had similar odds of any DGBI compared with those with normal BMI, whereas the odds progressively increased for overweight and obesity groups (class I: 1.20; 95% confidence interval [CI] 1.13–1.29; class II: 1.23; 95% CI 1.11–1.36; class III: 1.52; 95% CI 1.32–1.74). Every 5 kg/m 2 BMI increase above 25 kg/m 2 raised DGBI odds by 8% (95% CI 4%–11%). Associations were strongest for esophageal and gastroduodenal disorders. Higher BMI was associated with worse physical and mental health and greater anxiety and depression, irrespective of the presence of DGBI. DISCUSSION: Higher, but not lower, BMI is independently associated with increased prevalence and symptom burden of DGBI. Obesity confers the highest odds for overlapping disorders and psychological disturbances, underscoring the importance of integrated metabolic and behavioral management strategies.